b | Β | t | p | FDR < 5% | r | sr | |
---|---|---|---|---|---|---|---|
Dialysis | |||||||
HD (referent group) | |||||||
PD | −526.8 | −0.53 | −2.50 | 0.017 | ✓ | −0.31 | − 0.50 |
Confounders that were controlled | |||||||
Age (years) | −2.0 | −0.05 | −0.47 | 0.644 | −0.00 | −0.02 | |
Duration of dialysis (months) | −0.3 | −0.03 | − 0.18 | 0.856 | 0.08 | −0.12 | |
Number of teeth | 43.3 | 0.77 | 5.95 | < 0.001 | ✓ | 0.52 | 0.74 |
The last visit to the dentist | −13.4 | −0.11 | −0.99 | 0.327 | −0.06 | 0.03 | |
Smoking | |||||||
Non-smoker (referent group) | |||||||
Ex-smoker | 47.3 | 0.10 | 0.33 | 0.744 | −0.12 | −0.11 | |
Current smoker | 163.7 | 0.86 | 0.393 | ||||
Diabetes mellitus | − 418.0 | −0.43 | −1.73 | 0.092 | −0.09 | −0.26 | |
Duration of diabetes mellitus | 27.2 | 0.41 | 1.91 | 0.064 | −0.08 | 0.32 | |
HbA1ca | −44.1 | −0.10 | −0.69 | 0.495 | −0.14 | −0.04 | |
C-reactive protein (mg/L) | −9.5 | −0.28 | −2.12 | 0.041 | −0.15 | −0.42 | |
Kt/V | − 494.5 | −0.36 | −2.20 | 0.034 | ✓ | −0.21 | −0.28 |
Thrombocytes (109/L) | −2.2 | −0.35 | −1.80 | 0.081 | −0.11 | −0.04 | |
Leukocytes (109/L) | 22.5 | 0.12 | 0.78 | 0.442 | −0.06 | − 0.06 | |
Urea (mmol/L) | −4.9 | −0.06 | − 0.43 | 0.671 | 0.03 | −0.15 | |
Phosphorus (mmol/L) | 138.4 | 0.11 | 0.94 | 0.354 | 0.07 | 0.22 | |
HDL cholesterol (mmol/L) | −61.7 | −0.08 | −0.38 | 0.707 | −0.07 | 0.01 | |
Antihypertensive therapy | |||||||
Beta-blockers | −209.4 | −0.22 | −1.64 | 0.110 | 0.22 | −0.19 | |
Angiotensin-converting Enzyme inhibitors | − 216.5 | −0.20 | − 1.66 | 0.106 | 0.07 | 0.03 | |
Central α-2 receptor agents | 11.0 | 0.02 | 0.07 | 0.943 | 0.16 | 0.10 | |
Angiotensin II AT1-receptor blockers | − 159.1 | −0.11 | − 1.16 | 0.256 | 0.01 | 0.03 | |
α1-adrenoceptor antagonists | − 188.5 | −0.18 | −1.47 | 0.151 | 0.10 | −0.31 |